| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Pharmacology
2 Department of Biochemistry Biological Chemistry/HHMI University of Washington Seattle, WA 98195-7280
Correspondence: Send correspondence to JAB. E-mail beavo{at}u.washington.edu; fax 206-685-3822.
GAF domains represent one of the largest families of small-molecule binding units present in nature. The first mammalian GAF domains discovered were the cGMP-binding regulatory domains of several cyclic nucleotide phosphodiesterases (PDEs). The crystal structure of the PDE2A GAF domains has provided our first look at the architecture of the binding site for the second messenger cGMP. The topology of this site differs greatly from all other previously determined cyclic nucleotide binding sites. In PDE2A, cGMP binds to a well-defined pocket in one of the two GAF domains that is analogous to the ligand-binding pocket of the distantly related PAS domains of photoactive yellow protein and FixL. The consensus cGMP-binding motif suggests strongly that only certain GAF domains will bind cGMP. Although the detailed mechanism for how cGMP binding to the GAF domain regulates catalysis remains to be determined, recent data from a GAF domain–containing cAMP-stimulated adenylyl cyclase from Anabaena suggest a mechanism conserved across two billion years of evolution. Because of their unique ligand-binding topologies, the GAF domains of PDEs are likely to offer good new targets for rational drug design.
This article has been cited by other articles:
|
|
 |
|
  S. Schlag, S. Fuchs, C. Nerz, R. Gaupp, S. Engelmann, M. Liebeke, M. Lalk, M. Hecker, and F. Gotz Characterization of the Oxygen-Responsive NreABC Regulon of Staphylococcus aureus J. Bacteriol., December 1, 2008; 190(23): 7847 - 7858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Lee, H. Y. Cho, H. J. Cho, I.-J. Ko, S. W. Park, H.-S. Baik, J.-H. Oh, C.-Y. Eom, Y. M. Kim, B. S. Kang, et al. O2- and NO-Sensing Mechanism through the DevSR Two-Component System in Mycobacterium smegmatis J. Bacteriol., October 15, 2008; 190(20): 6795 - 6804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Martinez, C. C. Heikaus, R. E. Klevit, and J. A. Beavo The Structure of the GAF A Domain from Phosphodiesterase 6C Reveals Determinants of cGMP Binding, a Conserved Binding Surface, and a Large cGMP-dependent Conformational Change J. Biol. Chem., September 19, 2008; 283(38): 25913 - 25919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hofbauer, A. Schultz, and J. E. Schultz Functional Chimeras of the Phosphodiesterase 5 and 10 Tandem GAF Domains J. Biol. Chem., September 12, 2008; 283(37): 25164 - 25170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zou, Y. Zhu, E. L. Pohlmann, J. Li, Y. Zhang, and G. P. Roberts Identification and functional characterization of NifA variants that are independent of GlnB activation in the photosynthetic bacterium Rhodospirillum rubrum Microbiology, September 1, 2008; 154(9): 2689 - 2699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Heikaus, J. R. Stout, M. R. Sekharan, C. M. Eakin, P. Rajagopal, P. S. Brzovic, J. A. Beavo, and R. E. Klevit Solution Structure of the cGMP Binding GAF Domain from Phosphodiesterase 5: INSIGHTS INTO NUCLEOTIDE SPECIFICITY, DIMERIZATION, AND cGMP-DEPENDENT CONFORMATIONAL CHANGE J. Biol. Chem., August 15, 2008; 283(33): 22749 - 22759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Handa, E. Mizohata, S. Kishishita, M. Toyama, S. Morita, T. Uchikubo-Kamo, R. Akasaka, K. Omori, J. Kotera, T. Terada, et al. Crystal Structure of the GAF-B Domain from Human Phosphodiesterase 10A Complexed with Its Ligand, cAMP J. Biol. Chem., July 11, 2008; 283(28): 19657 - 19664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Newton, F. M. Sansom, J. Dao, C. Cazalet, H. Bruggemann, C. Albert-Weissenberger, C. Buchrieser, N. P. Cianciotto, and E. L. Hartland Significant Role for ladC in Initiation of Legionella pneumophila Infection Infect. Immun., July 1, 2008; 76(7): 3075 - 3085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kosaka, S. Kato, T. Shimoyama, S. Ishii, T. Abe, and K. Watanabe The genome of Pelotomaculum thermopropionicum reveals niche-associated evolution in anaerobic microbiota Genome Res., March 1, 2008; 18(3): 442 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Kass, H. C. Champion, and J. A. Beavo Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation Circ. Res., November 26, 2007; 101(11): 1084 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zaccolo and M. A. Movsesian cAMP and cGMP Signaling Cross-Talk: Role of Phosphodiesterases and Implications for Cardiac Pathophysiology Circ. Res., June 8, 2007; 100(11): 1569 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Brune, N. Jochmann, K. Brinkrolf, A. T. Huser, R. Gerstmeir, B. J. Eikmanns, J. Kalinowski, A. Puhler, and A. Tauch The IclR-Type Transcriptional Repressor LtbR Regulates the Expression of Leucine and Tryptophan Biosynthesis Genes in the Amino Acid Producer Corynebacterium glutamicum J. Bacteriol., April 1, 2007; 189(7): 2720 - 2733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Blount, R. Zoraghi, H. Ke, E. P. Bessay, J. D. Corbin, and S. H. Francis A 46-Amino Acid Segment in Phosphodiesterase-5 GAF-B Domain Provides for High Vardenafil Potency over Sildenafil and Tadalafil and Is Involved in Phosphodiesterase-5 Dimerization Mol. Pharmacol., November 1, 2006; 70(5): 1822 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cramer, R. Gerstmeir, S. Schaffer, M. Bott, and B. J. Eikmanns Identification of RamA, a Novel LuxR-Type Transcriptional Regulator of Genes Involved in Acetate Metabolism of Corynebacterium glutamicum. J. Bacteriol., April 1, 2006; 188(7): 2554 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gross-Langenhoff, K. Hofbauer, J. Weber, A. Schultz, and J. E. Schultz cAMP Is a Ligand for the Tandem GAF Domain of Human Phosphodiesterase 10 and cGMP for the Tandem GAF Domain of Phosphodiesterase 11 J. Biol. Chem., February 3, 2006; 281(5): 2841 - 2846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mongillo, C. G. Tocchetti, A. Terrin, V. Lissandron, Y.-F. Cheung, W. R. Dostmann, T. Pozzan, D. A. Kass, N. Paolocci, M. D. Houslay, et al. Compartmentalized Phosphodiesterase-2 Activity Blunts {beta}-Adrenergic Cardiac Inotropy via an NO/cGMP-Dependent Pathway Circ. Res., February 3, 2006; 98(2): 226 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zoraghi, E. P. Bessay, J. D. Corbin, and S. H. Francis Structural and Functional Features in Human PDE5A1 Regulatory Domain That Provide for Allosteric cGMP Binding, Dimerization, and Regulation J. Biol. Chem., March 25, 2005; 280(12): 12051 - 12063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Laxman, A. Rascon, and J. A. Beavo Trypanosome Cyclic Nucleotide Phosphodiesterase 2B Binds cAMP through Its GAF-A Domain J. Biol. Chem., February 4, 2005; 280(5): 3771 - 3779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zoraghi, J. D. Corbin, and S. H. Francis Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins Mol. Pharmacol., February 1, 2004; 65(2): 267 - 278. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |
